JP2017515802A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017515802A5 JP2017515802A5 JP2016561626A JP2016561626A JP2017515802A5 JP 2017515802 A5 JP2017515802 A5 JP 2017515802A5 JP 2016561626 A JP2016561626 A JP 2016561626A JP 2016561626 A JP2016561626 A JP 2016561626A JP 2017515802 A5 JP2017515802 A5 JP 2017515802A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- halo
- cancer
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461976880P | 2014-04-08 | 2014-04-08 | |
| US61/976,880 | 2014-04-08 | ||
| US201462019577P | 2014-07-01 | 2014-07-01 | |
| US62/019,577 | 2014-07-01 | ||
| PCT/US2015/024146 WO2015157093A1 (en) | 2014-04-08 | 2015-04-02 | 2,3-disubstituted pyridine compounds as tgf-beta inhibitors and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019134857A Division JP2019196387A (ja) | 2014-04-08 | 2019-07-22 | Ｔｇｆ−ベータ阻害剤としての２，３−二置換ピリジン化合物および使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017515802A JP2017515802A (ja) | 2017-06-15 |
| JP2017515802A5 true JP2017515802A5 (https=) | 2018-05-24 |
| JP6767875B2 JP6767875B2 (ja) | 2020-10-14 |
Family
ID=52875332
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016561626A Expired - Fee Related JP6767875B2 (ja) | 2014-04-08 | 2015-04-02 | Ｔｇｆ−ベータ阻害剤としての２，３−二置換ピリジン化合物および使用方法 |
| JP2019134857A Withdrawn JP2019196387A (ja) | 2014-04-08 | 2019-07-22 | Ｔｇｆ−ベータ阻害剤としての２，３−二置換ピリジン化合物および使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019134857A Withdrawn JP2019196387A (ja) | 2014-04-08 | 2019-07-22 | Ｔｇｆ−ベータ阻害剤としての２，３−二置換ピリジン化合物および使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10233170B2 (https=) |
| EP (1) | EP3129367B1 (https=) |
| JP (2) | JP6767875B2 (https=) |
| CN (1) | CN106536507B (https=) |
| ES (1) | ES2759240T3 (https=) |
| TW (1) | TW201623279A (https=) |
| UY (1) | UY36068A (https=) |
| WO (1) | WO2015157093A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106536507B (zh) * | 2014-04-08 | 2020-04-07 | 里格尔药品股份有限公司 | 作为TGF-β抑制剂的2,3-二取代的吡啶化合物及其使用方法 |
| CN107531666A (zh) | 2015-02-20 | 2018-01-02 | 里格尔药品股份有限公司 | Gdf‑8抑制剂 |
| AU2016311426B2 (en) | 2015-08-26 | 2021-05-20 | Blueprint Medicines Corporation | Compounds and compositions useful for treating disorders related to NTRK |
| MX2018006195A (es) | 2015-11-19 | 2018-09-05 | Blueprint Medicines Corp | Compuestos y composiciones utiles para el tratamiento de trastornos relacionados con ntrk. |
| CA3006300C (en) * | 2015-11-25 | 2024-02-27 | Convergene Llc | Bicyclic bet bromodomain inhibitors and uses thereof |
| SG11201808306PA (en) * | 2016-03-24 | 2018-10-30 | Tragara Pharmaceuticals Inc | Treatment of cancer with tg02 |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
| EP3532604A4 (en) * | 2016-10-26 | 2020-06-03 | Icahn School of Medicine at Mount Sinai | METHOD FOR INCREASING CELL PROLIFERATION IN PANCREATIC BETA CELLS, TREATMENT METHOD AND COMPOSITION |
| ES2928773T3 (es) | 2017-01-17 | 2022-11-22 | Heparegenix Gmbh | Inhibidores de proteína cinasas para fomentar la regeneración hepática o reducir o prevenir la muerte de hepatocitos |
| MX2019008696A (es) * | 2017-01-23 | 2019-09-13 | Revolution Medicines Inc | Compuestos de piridina como inhibidores de shp2 alostericos. |
| US11078188B2 (en) * | 2017-03-08 | 2021-08-03 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereof |
| CN107118210A (zh) * | 2017-04-28 | 2017-09-01 | 贵州大学 | 一种3‑碘‑6‑（三氟甲基）咪唑并[1,2‑a]吡啶的制备工艺 |
| CA3084581A1 (en) | 2017-11-20 | 2019-05-23 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| WO2019136320A1 (en) | 2018-01-05 | 2019-07-11 | Icahn School Of Medicine At Mount Sinai | Method of increasing proliferation of pancreatic beta cells, treatment method, and composition |
| JP2021518413A (ja) | 2018-03-20 | 2021-08-02 | アイカーン スクール オブ メディシン アット マウント サイナイ | キナーゼ阻害剤化合物及び組成物ならびに使用方法 |
| US12419865B2 (en) | 2018-12-06 | 2025-09-23 | Arisan Therapeutics Inc. | Compounds for the treatment of arenavirus infection |
| CA3117838A1 (en) | 2018-12-27 | 2020-07-02 | Nexys Therapeutics, Inc. | (pyridin-2-yl)amine derivatives as tgf-beta r1 (alk5) inhibitors for the treatment of cancer |
| EP3904348A4 (en) * | 2018-12-28 | 2022-10-19 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | AMINOPYRIMIDINE COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF |
| PH12021500043A1 (en) | 2019-03-29 | 2022-06-06 | Sumitomo Chemical Co | Heterocyclic compound and harmful arthropod pest control composition containing same |
| AU2020266529B2 (en) | 2019-04-29 | 2026-01-29 | Solent Therapeutics, Llc | 3-amino-4H-benzo[E][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2 |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| CN115916759B (zh) * | 2020-06-19 | 2025-07-15 | 泰州红云制药有限公司 | 取代喹唑啉类化合物、其制备方法、药物组合及应用 |
| US20230234935A1 (en) * | 2020-06-26 | 2023-07-27 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| BR112023005876A2 (pt) | 2020-09-30 | 2023-05-02 | Sumitomo Chemical Co | Composto heterocíclico e composição de controle de artrópode nocivo contendo o mesmo |
| CN112225736B (zh) * | 2020-11-12 | 2022-04-15 | 山东省科学院菏泽分院 | 一种6-溴咪唑并[1.2-a]吡啶-3-甲醛的制备方法 |
| US20240277852A1 (en) * | 2021-05-20 | 2024-08-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors and degraders of pip4k protein |
| CN113416181B (zh) * | 2021-08-02 | 2022-05-03 | 四川大学 | 喹唑啉类衍生物及其用途 |
| CN114292259B (zh) * | 2021-11-30 | 2023-06-27 | 西安交通大学 | 4-氨基酸侧链取代的喹唑啉衍生物及其应用 |
| KR20240133695A (ko) * | 2021-12-10 | 2024-09-04 | 프로테나 바이오사이언시즈 리미티드 | Dyrk1a 억제제로서의 헤테로시클릭 화합물 |
| WO2024071393A1 (ja) | 2022-09-30 | 2024-04-04 | 住友化学株式会社 | 複素環化合物及びそれを含有する有害節足動物防除組成物 |
| WO2024096093A1 (ja) | 2022-11-04 | 2024-05-10 | 住友化学株式会社 | 複素環化合物及びそれを含有する有害節足動物防除組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7320789B2 (en) * | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
| US20070185152A1 (en) * | 2004-03-02 | 2007-08-09 | Smithkline Beecham Corporation | Inhibitors of akt activity |
| EP1804801A2 (en) * | 2004-10-15 | 2007-07-11 | Biogen Idec MA, Inc. | Methods of treating vascular injuries |
| US9259426B2 (en) * | 2006-07-20 | 2016-02-16 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| ES2375425T3 (es) | 2007-07-26 | 2012-02-29 | Novartis Ag | Compuestos org�?nicos. |
| WO2009032653A1 (en) * | 2007-08-31 | 2009-03-12 | Smith Kline Beecham Corporation | Inhibitors of akt activity |
| AU2010344973B2 (en) * | 2010-02-05 | 2016-06-16 | Merck Patent Gmbh | Hetaryl-[1,8]naphthyridine derivatives |
| MX2013010163A (es) * | 2011-03-09 | 2013-10-30 | Merck Patent Gmbh | Derivados de pirido[2,3-b] pirazina y sus usos terapeuticos. |
| DK2731949T3 (en) * | 2011-07-13 | 2018-06-14 | Tiumbio Co Ltd | 2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND / OR ALK4 INHIBITORS |
| KR20150072412A (ko) * | 2012-10-05 | 2015-06-29 | 리겔 파마슈티칼스, 인크. | Gdf-8 억제제 |
| CN106536507B (zh) * | 2014-04-08 | 2020-04-07 | 里格尔药品股份有限公司 | 作为TGF-β抑制剂的2,3-二取代的吡啶化合物及其使用方法 |
-
2015
- 2015-04-02 CN CN201580030111.XA patent/CN106536507B/zh not_active Expired - Fee Related
- 2015-04-02 JP JP2016561626A patent/JP6767875B2/ja not_active Expired - Fee Related
- 2015-04-02 WO PCT/US2015/024146 patent/WO2015157093A1/en not_active Ceased
- 2015-04-02 EP EP15716690.1A patent/EP3129367B1/en active Active
- 2015-04-02 US US15/128,051 patent/US10233170B2/en active Active
- 2015-04-02 ES ES15716690T patent/ES2759240T3/es active Active
- 2015-04-08 TW TW104111332A patent/TW201623279A/zh unknown
- 2015-04-08 UY UY0001036068A patent/UY36068A/es unknown
-
2019
- 2019-01-16 US US16/249,458 patent/US10858335B2/en not_active Expired - Fee Related
- 2019-07-22 JP JP2019134857A patent/JP2019196387A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017515802A5 (https=) | ||
| AU2021225157B2 (en) | Combination therapy of tetracyclic quinolone analogs for treating cancer | |
| ES2986067T3 (es) | Moléculas de anticuerpos frente a PD-1 y usos de las mismas | |
| KR20190130612A (ko) | 개질된 사이클릭 디뉴클레오타이드 화합물 | |
| RU2017145026A (ru) | Соединение, ингибирующее brk | |
| JP2017528524A5 (https=) | ||
| RU2015103151A (ru) | Усилитель противоопухолевого эффекта, содержащий имидазооксазиновое соединение | |
| CA3145391A1 (en) | Pharmaceutical composition for treating acute myeloid leukemia, containing flt3 inhibitor and chemotherapeutic agents | |
| CA3115068A1 (en) | Method for preparing and delivering bisantrene formulations | |
| CN111836621A (zh) | 使用1,2,4-噁二唑化合物调节tigit和pd-1信号传导途径的方法 | |
| JPWO2020032105A5 (https=) | ||
| CN111386275A (zh) | 高活性sting蛋白激动剂 | |
| KR20210079313A (ko) | 암 치료에서 면역 조절을 위한 조합 | |
| CN116888119A (zh) | 腺苷A2a受体的拮抗剂 | |
| JP7293108B2 (ja) | Ａｘｌ阻害剤とＥＧＦＲチロシンキナーゼ阻害薬との併用治療法 | |
| JP7479292B2 (ja) | 組み合わせ医薬として用いられるｅｚｈ１／２二重阻害剤を含有する医薬組成物 | |
| WO2008132500A2 (en) | Chkl inhibitors with b cell depleting antibodies for the treatment of hematologic malignancies | |
| TW201343169A (zh) | 使用奧諾拉（ａｕｒｏｒａ）激酶抑制劑治療癌症的方法 | |
| JP2025525960A (ja) | Ｃｄｋ７阻害剤と他の抗がん療法との組み合わせ療法 | |
| KR20200037354A (ko) | 항종양제 및 항종양 효과 증강제 | |
| HK1261603B (en) | Combination therapy of tetracyclic quinolone analogs for treating cancer | |
| HK1261603A1 (en) | Combination therapy of tetracyclic quinolone analogs for treating cancer |